COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society
19/02/2019
- Presentations highlighted data analyses across multiple disease states - - New, nonclinical data indicates potential for suprachoroidal administration of gene-based therapies - ALPHARETTA, Ga., Feb. 19, 2019 (GLOBE [...]
The Joint Corp. Opens First Corporately Managed Greenfield Clinic Since 2016
19/02/2019
- Grew Total Clinics to 442 at December 31, 2018 - - Increased Corporate Clinic Count to 49 as of February 15, 2019 - SCOTTSDALE, Ariz., Feb. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national [...]
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
19/02/2019
March 24, 2019 PDUFA Goal Date for IV Meloxicam Record CDMO Performance; 2018 Revenues of $77.3 Million Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, [...]
Axovant to Present at 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019
NEW YORK and BASEL, Switzerland, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu, M.D., chief [...]
William Demant Holding A/S: Notice to annual general meeting
19/02/2019
To the shareholders of William Demant Holding A/S 19 February 2019 Notice is hereby given of the Annual General Meeting of William Demant Holding A/S to be held on: Tuesday, 19 March 2019 at 4:00pm CET at the Company’s [...]
Transactions in relation to share buyback program
19/02/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Helsinn Investment Fund Invests €1 Million in Gain Therapeutics
19/02/2019
Helsinn Investment Fund Invests €1 Million in Gain Therapeutics Luxembourg, February 19, 2019: Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage investment opportunities in areas of high unmet patient [...]
Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany
19/02/2019
Interim report for Enzymatica AB (publ) JANUARY- DECEMBER 2018 Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany Q4 Net sales reached SEK 18.9 (19.1) million. [...]
Motif Bio Conference Call and Webcast
19/02/2019
NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company will hold a [...]
Agreement between Bio-on and Innova Imagen for the production of Bioplastic in Mexico
19/02/2019
Bio-on and Innova Imagen (Himes Group) announce the signing of a new agreement to produce ultra-green PHA biopolymers in Mexico The two companies start the first collaboration in the central / north America, to exploit [...]
Saniona Tesomet Phase 2a Prader-Willi syndrome trial update
19/02/2019
PRESS RELEASE February 19, 2019 Tesomet 0.5 mg/day achieved reductions in weight and hyperphagia in adult PWS patients Tesomet 0.125 mg/day was well tolerated in adolescent PWS patients, but did not achieve sufficient [...]
William Demant Holding A/S: Investor news - William Demant Holding changes name to Demant
19/02/2019
Investor news 19 February 2019 William Demant Holding changes name to Demant William Demant Holding A/S proposes to change its name to Demant A/S. At the Annual General Meeting, the Company will ask the shareholders to [...]
William Demant Holding A/S: Annual Report 2018
19/02/2019
Company announcement no 2019-02 19 February 2019 Strong revenue growth of 9% in local currencies exceeding the market growth rate 8% growth in EBIT (6% adjusted) with unprecedented level of resources used to drive [...]
Basilea reports strong revenue growth and significant pipeline progress for full-year 2018
19/02/2019
Total revenue increased 31% to CHF 133 million Revenue from Cresemba ® and Zevtera ® increased 56% to CHF 82 million Positive derazantinib phase 2 interim results and collaboration with Roche on combination with [...]
New Milestone for Cansativa Towards “EU GxP Innovation Hub”
19/02/2019
Northern Swan invests millions in pharma startup Cansativa FRANKFURT, Germany, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in [...]
Vistin Pharma ASA : Fourth quarter 2018 financial results
19/02/2019
Oslo, Norway, 19 February 2019 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter of 2018 in line with the business updates from the company on 4 and 8 January [...]
MDxHealth (R): MDxHealth Appoints Michael K. McGarrity as CEO
19/02/2019
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION February 19, 2019 - 07:00 CET Dr. Jan Groen continues as an advisor to the Board IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, February 19, 2019 - MDxHealth SA ( [...]
MDxHealth (R) : MDxHealth nomme Michael K. McGarrity au poste de CEO
19/02/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES INFORMATIONS INTERNES 19 février 2019 - 07:00 CET Dr Jan Groen devient conseiller du Conseil d'administration IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CET, 19 février 2019 [...]
Precipio Provides Corporate Update Shareholder Call
18/02/2019
Conference Call to be held Thursday February 21st, 2019 at 4:30pm Eastern Time NEW HAVEN, Conn., Feb. 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), will host a conference [...]

Pages